Logos Global Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64M | Hold |
1,200,000
| – | – | 7.08% | 2 |
|
|
2025
Q1 | $48.6M | Buy |
1,200,000
+400,000
| +50% | +$16.2M | 8.64% | 3 |
|
|
2024
Q4 | $22.3M | Hold |
800,000
| – | – | 2.6% | 14 |
|
|
2024
Q3 | $23M | Hold |
800,000
| – | – | 2.48% | 15 |
|
|
2024
Q2 | $18.8M | Hold |
800,000
| – | – | 1.51% | 15 |
|
|
2024
Q1 | $20.2M | Hold |
800,000
| – | – | 1.64% | 19 |
|
|
2023
Q4 | $18.7M | Buy |
800,000
+200,000
| +33% | +$4.67M | 1.74% | 15 |
|
|
2023
Q3 | $30.3M | Buy |
600,000
+80,000
| +15% | +$4.05M | 4.05% | 6 |
|
|
2023
Q2 | $24.3M | Buy |
520,000
+120,000
| +30% | +$5.6M | 3.3% | 11 |
|
|
2023
Q1 | $15.3M | Hold |
400,000
| – | – | 2.19% | 19 |
|
|
2022
Q4 | $21.9M | Hold |
400,000
| – | – | 2.57% | 16 |
|
|
2022
Q3 | $13.6M | Buy |
+400,000
| New | +$13.6M | 1.67% | 20 |
|